Latest news

Daily Snap - 22. October 2025

Daily Snap - 22. October 2025

Joachim Eeckhout
GSK revives rejected antibiotic with phase 3 win for oral UTI treatment

GSK revives rejected antibiotic with phase 3 win for oral UTI treatment

Joachim Eeckhout
BioNTech halts late-stage melanoma vaccine despite promising data

BioNTech halts late-stage melanoma vaccine despite promising data

Joachim Eeckhout
Daily Snap - 21. October 2025

Daily Snap - 21. October 2025

Joachim Eeckhout
Summit’s lung cancer drug shows promise, but market skepticism lingers

Summit’s lung cancer drug shows promise, but market skepticism lingers

Joachim Eeckhout
Tubulis’ ADC shows 59% response rate, fueling investor and clinical momentum

Tubulis’ ADC shows 59% response rate, fueling investor and clinical momentum

Joachim Eeckhout
Daily Snap - 20. October 2025

Daily Snap - 20. October 2025

Joachim Eeckhout
Roche breast cancer pill slashes progression risk by 62% in key trial

Roche breast cancer pill slashes progression risk by 62% in key trial

Joachim Eeckhout
Evaxion’s cancer vaccine shows 75% response but funding shortfall limits trial impact

Evaxion’s cancer vaccine shows 75% response but funding shortfall limits trial impact

Joachim Eeckhout
Daily Snap - 17. October 2025

Daily Snap - 17. October 2025

Joachim Eeckhout
Adcytherix raises €105M to supercharge next-gen cancer therapies

Adcytherix raises €105M to supercharge next-gen cancer therapies

Joachim Eeckhout
Praxis’ tremor drug triumph sends stock soaring 200%+

Praxis’ tremor drug triumph sends stock soaring 200%+

Joachim Eeckhout
FirstBack
23456789
Next Last